1. Home
  2. IFRX vs TLYS Comparison

IFRX vs TLYS Comparison

Compare IFRX & TLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IFRX
  • TLYS
  • Stock Information
  • Founded
  • IFRX 2007
  • TLYS 1982
  • Country
  • IFRX Germany
  • TLYS United States
  • Employees
  • IFRX N/A
  • TLYS N/A
  • Industry
  • IFRX Biotechnology: Pharmaceutical Preparations
  • TLYS Clothing/Shoe/Accessory Stores
  • Sector
  • IFRX Health Care
  • TLYS Consumer Discretionary
  • Exchange
  • IFRX Nasdaq
  • TLYS Nasdaq
  • Market Cap
  • IFRX 53.5M
  • TLYS 44.0M
  • IPO Year
  • IFRX 2017
  • TLYS 2012
  • Fundamental
  • Price
  • IFRX $1.26
  • TLYS $1.54
  • Analyst Decision
  • IFRX Strong Buy
  • TLYS Hold
  • Analyst Count
  • IFRX 5
  • TLYS 2
  • Target Price
  • IFRX $7.40
  • TLYS $2.25
  • AVG Volume (30 Days)
  • IFRX 486.5K
  • TLYS 83.0K
  • Earning Date
  • IFRX 11-07-2025
  • TLYS 12-04-2025
  • Dividend Yield
  • IFRX N/A
  • TLYS N/A
  • EPS Growth
  • IFRX N/A
  • TLYS N/A
  • EPS
  • IFRX N/A
  • TLYS N/A
  • Revenue
  • IFRX $191,224.00
  • TLYS $549,597,000.00
  • Revenue This Year
  • IFRX N/A
  • TLYS N/A
  • Revenue Next Year
  • IFRX $1,216.24
  • TLYS $1.18
  • P/E Ratio
  • IFRX N/A
  • TLYS N/A
  • Revenue Growth
  • IFRX 54.36
  • TLYS N/A
  • 52 Week Low
  • IFRX $0.71
  • TLYS $0.57
  • 52 Week High
  • IFRX $2.82
  • TLYS $4.77
  • Technical
  • Relative Strength Index (RSI)
  • IFRX 47.21
  • TLYS 35.24
  • Support Level
  • IFRX $1.14
  • TLYS $1.48
  • Resistance Level
  • IFRX $1.44
  • TLYS $1.77
  • Average True Range (ATR)
  • IFRX 0.14
  • TLYS 0.13
  • MACD
  • IFRX -0.04
  • TLYS -0.05
  • Stochastic Oscillator
  • IFRX 24.00
  • TLYS 6.56

About IFRX InflaRx N.V.

InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.

About TLYS Tilly's Inc.

Tilly's Inc works as a specialty retailer of casual apparel, footwear, and accessories for young men, young women, boys, and girls. It offers an unparalleled selection of relevant brands, styles, colors, sizes, and price points. It delivers branded fashion, and core styles for tops, outerwear, bottoms, and dresses. It also provides backpacks, hats, sunglasses, headphones, handbags, watches, and jewelry. It markets its products under the brand names of Vans, RVCA, Adidas, Nike SB, and Hurley among others. It operates its stores in malls, lifestyle centers, power centers, community centers, outlet centers, street-front locations, and also through e-commerce.

Share on Social Networks: